Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(3)
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
Block Deal
|
Mid-range Performer
4823.5000
-20.00
(
-0.41
%)
NSE
Jun 06, 2025
11:54 AM
25.10% Fall from 52W High
Volume:
89,940
High vol. this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
20 May 2023
Block Deal
4823.50
-0.41%
4Q - A Miss; Ends FY23 on weakest margins since past 5-years
Neutral:
Alkem Laboratories Ltd.
by
Motilal Oswal
Target: 3470
Target
Motilal Oswal
Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended
Market trades higher, RBI cuts the policy repo rate by 50 bps to 5.5%
Trendlyne Marketwatch |
06 Jun 2025, 11:47AM
Largecaps to see new entries and exits, with reclassification | Screener: Stocks outperforming in ROE
The Baseline |
04 Jun 2025, 02:48PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021